Italia markets closed

FTSE MIB
33.922,16
+40,66(+0,12%)
Dow Jones
37.955,49
+180,11(+0,48%)
Nasdaq
15.337,54
-263,96(-1,69%)
Nikkei 225
37.068,35
-1.011,35(-2,66%)
Petrolio
83,13
+0,40(+0,48%)
Bitcoin EUR
60.475,71
+1.846,02(+3,15%)

Alcon Inc. (0A0D.L)

LSE - LSE Prezzo differito. Valuta in CHF.

Aggiungi a watchlist

71,77

+1,43

(+2,04%)

Alla chiusura: 06:02PM BST

Capitalizzazione	346,546M
Beta (5 anni mensile)	0,67
Rapporto PE (ttm)	0,79
EPS (ttm)	0,91
Prossima data utili	N/D
Rendimento e dividendo (futuro)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loanCHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a broad set of agreements with its long-term customer, Alcon (SIX/NYSE: ALC), which provides for the repayment of the Company’s